Gamma-delta T cell therapy (CD16+)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gamma-delta T cell therapy (CD16+), covering 2024-12-24 to 2024-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection [Phase 2]